S&P 500 (NYSE:SPY) component CareFusion (NYSE:CFN) will unveil its latest earnings on Monday, August 8, 2011. CareFusion Corp is a medical technology company offering clinically proven products and services designed to improve the safety and quality of healthcare.
CareFusion Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of 50 cents per share, a rise of 31.6% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 51 cents. Between one and three months ago, the average estimate moved down, but it has been unchanged at 50 cents during the last month. For the year, analysts are projecting net income of $1.63 per share, a rise of 14.8% from last year.
Past Earnings Performance: The company is looking to beat analyst estimates for the third quarter in a row. Last quarter, it beat estimates with profit of 42 cents per share against the mean estimate of 40 cents. In the prior quarter, the company reported net income of 44 cents.
Wall St. Revenue Expectations: On average, analysts predict $967.2 million in revenue this quarter, a decline of 7% from the year ago quarter. Analysts are forecasting total revenue of $3.54 billion for the year, a decline of 9.9% from last year’s revenue of $3.93 billion.
Analyst Ratings: Analysts are bullish on CareFusion as six analysts rate it as a buy, none rate it as a sell and six rate it as a hold.
Revenue has fallen in the past four quarters. Revenue declined 8.9% to $867 million in third quarter. The figure fell 1.7% in the second quarter from the year earlier, dropped 1.6% in first quarter from the year-ago quarter and 5.2% in the fourth quarter of the last fiscal year.
Competitors to Watch: Teleflex Incorporated (NYSE:TFX), Covidien plc (NYSE:COV), Thermo Fisher Scientific Inc. (NYSE:TMO), Cardinal Health, Inc. (NYSE:CAH), Masimo Corporation (NASDAQ:MASI), Angeion Corporation (NASDAQ:ANGN), NeuroMetrix, Inc. (NASDAQ:NURO), Baxter International Inc. (NYSE:BAX), C.R. Bard, Inc. (NYSE:BCR), and Stryker Corporation (NYSE:SYK).
Stock Price Performance: During May 6, 2011 to August 2, 2011, the stock price had fallen $4.65 (-15.9%) from $29.20 to $24.55. It saw one of its worst periods between July 21, 2011 and August 2, 2011 when shares fell for nine-straight days, falling 12.8% (-$3.59) over that span. The stock price saw one of its best stretches over the last year between June 29, 2011 and July 7, 2011 when shares rose for six-straight days, rising 5% (+$1.35) over that span. Shares are down $1.15 (-4.5%) year to date.
(Source: Xignite Financials)